Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Propranolol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Ulcer 1 Smoldering Multiple Myeloma 1 Skin Neoplasms 1 Sarcoma, Kaposi 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Liver Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangioma, Capillary 1 Fallopian Tube Neoplasms 1 Digestive System Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Ovarian Epithelial 1 Biliary Tract Neoplasms 1

Interventions

pembrolizumab 32 Blood Specimen Collection 30 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 14 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Drug Therapy 11 Cisplatin 11 atezolizumab 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 9 Trastuzumab 8 Pemetrexed 8 Fluorouracil 8 pertuzumab 7 olaparib 7 Temozolomide 7 Leucovorin 7 Irinotecan 7 Interviews as Topic 7 Cetuximab 7 Radiosurgery 6 Panitumumab 6 Oxaliplatin 6 Observation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06839144 2025-07-11

OC-POP-PT

Tel-Aviv Sourasky Medical Center

Phase 2 Recruiting

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡